Sanofi-Aventis Details Plans for Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
As Big Pharma strives to educate Wall Street on the promise of emerging markets, Sanofi-Aventis has come out swinging: in a statistic-filled July 2 analyst forum, top executives noted they have a bigger market share and more experience than rivals in some of the fastest-growing countries